H3B-6545

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

H3B-6545

CAS No. : 2052130-80-8

MCE 国际站：H3B-6545

产品活性：H3B-6545 是一种有效的，具有口服活性的选择性雌激素受体共价拮抗剂 (SERCA)。H3B-6545 可用于研究转移性 ER 阳性，HER2 阴性乳腺癌。

研究领域：Vitamin D Related/Nuclear Receptor

作用靶点：Estrogen Receptor/ERR

In Vitro: H3B-6545 is a highly selective small molecule that potently antagonizes wild-type and mutant ERα in biochemical and cell based assays. In vitro comparisons with standard of care and other experimental agents confirm increased cell potency of H3B-6545 under continuous as well as washout treatment conditions. H3B-6545, a member of a novel class of ERα antagonists refer to as selective ER covalent antagonist (SERCA), which inactivates both wild-type and mutant ERα by targeting C530 and enforcing a unique antagonist conformation. H3B-6545 is a first-in-class selective ER covalent antagonist (SERCA). H3B-6545 inhibits ERα^WT activity and growth of ERα^WT -positive breast cancer lines. H3B-6545 potently inhibits ERα^WT activity and suppresses proliferation of ERα^WT -positive breast cancer lines. With GI₅₀s of 0.3-0.4, 1.0, 0.5, 5.2, and 0.2 nM for MCF7, HCC1428, BT483, T47D and CAMA-1 cell lines.

In Vivo: In vivo, once daily oral dosing of H3B-6545 shows potent activity and superior efficacy to fulvestrant in the MCF-7 xenograft model with maximal antitumor activity at doses >10x below the maximum tolerated dose in mice. In addition, H3B-6545 shows superior antitumor activity to Tamoxifen and Fulvestrant in patient derived xenograft models of estrogen receptor positive breast cancer including models carrying ERα mutations in rat and monkeys, H3B-6545 is well tolerated across a broad dose range and at exposures that significantly exceed those required for efficacy in mouse xenograft models.

相关产品：Covalent Screening Library Plus  |  Natural Product-like Compound Library  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Orally Active Compound Library  |  Anti-Breast Cancer Compound Library  |  Nuclear Receptor Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Tamoxifen  |  Estradiol  |  Fulvestrant  |  4-Hydroxytamoxifen  |  Cholesterol  |  Kaempferol  |  G15  |  G-1  |  Vepdegestrant  |  PHTPP  |  Elacestrant  |  27-Hydroxycholesterol  |  Estrone  |  Raloxifene hydrochloride  |  DPN  |  Camizestrant  |  Propyl pyrazole triol  |  XCT790  |  Liquiritigenin  |  AZD9496  |  Zearalenone  |  Saikosaponin D  |  Giredestrant  |  Chrysin  |  Bazedoxifene

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds